CVS Health Corporation [CVS] shares are down more than -9.31% this year and recently increased 0.01% or $0.81 to settle at $59.32. Analysts expect CVS to grow earnings at a 6.34% annual rate over the next 5 years. CVS has a short ratio of 2.56. This implies that the market is currently less bullish on the outlook for CVS.

On 7, October 2020, CVS Health Corporation Announces Quarterly Dividend. According to news published on Yahoo Finance, CVS Health Corporation (NYSE: CVS) today announced that its board of directors has approved a quarterly dividend of $0.50 (50 cents) per share on the corporation’s common stock. The dividend is payable on November 2, 2020, to holders of record on October 22, 2020.

Analyst Birdseye View:

The most recent analyst activity for CVS Health Corporation [NYSE:CVS] stock was on July 01, 2020, when it was Initiated with a Mkt perform rating from SVB Leerink, which also raised its 12-month price target on the stock to $72. Before that, on September 17, 2020, Piper Sandler Recapitulated an Overweight rating and elevated its amount target to $72. On May 14, 2020, Credit Suisse Upgrade an Outperform rating and boosted its price target on this stock to $75. On September 27, 2019, RBC Capital Mkts Resumed an Outperform rating and increased its price target to $85. On September 12, 2019, Deutsche Bank Initiated a Buy rating. On June 05, 2019, Standpoint Research Upgrade a Buy rating. On April 29, 2019, Credit Suisse Downgrade a Neutral rating and decreased its target amount on this stock from $73 to $61.

In the past 52 weeks of trading, this stock has oscillated between a low of $52.04 and a peak of $77.03. Right now, the middling Wall Street analyst 12-month amount mark is $80.00. At the most recent market close, shares of CVS Health Corporation [NYSE:CVS] were valued at $59.32. According to the average price forecast, investors can expect a potential return of 0.7%.

FUNDAMENTAL ANALYSIS

CVS Health Corporation [NYSE:CVS] most recently reported quarterly sales of 65.29 billion, which represented growth of 3.00%. This publicly-traded organization’s revenue is $884,748 per employee, while its income is $22,859 per employee. This company’s Gross Margin is currently 38.20%, its Operating Margin is 5.30%, its Pretax Margin is +3.51, and its Net Margin is +2.58. Continuing to look at profitability, this corporation’s Return on Assets, Equity, Whole Principal & invested Principal is sitting at 3.14, 10.86, 8.91 and 4.78 respectively.

The Principal structure of this organization shows its whole liability to whole principal at 58.22 and the whole liability to whole assets at 39.68. It shows enduring liability to the whole principal at 54.70 and enduring liability to assets at 0.37 while looking for an extended time period.

Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 58.38 points at 1st support level, the second support level is making up to 57.43. But as of 1st resistance point, this stock is sitting at 59.80 and at 60.27 for 2nd resistance point.

CVS Health Corporation [CVS] reported its earnings at $2.64 per share in the fiscal quarter closing of 6/29/2020. The Analysts for Wall Street were expecting to report its earnings at $1.93/share signifying the difference of 0.71 and 36.80% surprise value. Comparing the previous quarter ending of 3/30/2020, the stated earnings were $1.91 calling estimates for $1.63/share with the difference of 0.28 depicting the surprise of 17.20%.

Important Ratio’s To Watch

Meanwhile, turning our focus to liquidity, the Current Ratio for CVS Health Corporation [NYSE:CVS] is 1.00. Likewise, the Quick ratio is also the same, showing Cash ratio at 0.15. Now if looking for a valuation of this stock’s amount to sales ratio it’s 0.38, it’s amount to book ratio is 1.51 and showing 9.41 of P/E (TTM) ratio.

Insider Stories

The most recent insider trade was by Mayhew Jonathan E., EVP – Transformation, and it was the sale of 10556.0 shares on May 26. Clark James David, the SVP, Cont & Chief Acct Officer, completed a sale of 270.0 shares on May 26. On May 11, Lotvin Alan, EVP and President-CVS Caremark, completed a purchase of 5000.0 shares.